US Stock MarketDetailed Quotes

TLIS Talis Biomedical

Watchlist
  • 4.3600
  • +0.2200+5.31%
Close Aug 16 16:00 ET
  • 4.3000
  • -0.0600-1.38%
Post 20:01 ET
7.94MMarket Cap-138P/E (TTM)

Talis Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-46.72%73K
-88.72%412K
41.12%151K
-89.59%76K
-90.44%48K
-94.08%137K
3.65M
107K
730K
502K
Operating revenue
-46.72%73K
-88.72%412K
41.12%151K
-89.59%76K
-90.44%48K
-94.08%137K
--3.65M
--107K
--730K
--502K
Cost of revenue
-70.00%6K
-99.51%41K
-99.66%8K
-99.51%6K
-99.46%7K
-99.43%20K
8.39M
2.33M
1.24M
1.3M
Gross profit
-42.74%67K
107.83%371K
106.43%143K
113.83%70K
105.13%41K
109.69%117K
-4.74M
-2.23M
-506K
-800K
Operating expense
-25.79%14.18M
-39.14%67.19M
-43.61%14.6M
-35.16%17.04M
-37.93%16.43M
-39.82%19.11M
-42.44%110.4M
-9.23%25.89M
-31.59%26.28M
-58.87%26.47M
Selling and administrative expenses
82.08%11.65M
-30.73%28.21M
-38.85%6.6M
-0.25%8.8M
-30.16%6.41M
-46.36%6.4M
-3.98%40.73M
-12.34%10.8M
-31.01%8.83M
-8.06%9.18M
Research and development costs
-81.64%2.53M
-42.55%40.69M
-47.24%8.04M
-52.62%8.3M
-39.22%10.56M
-33.36%13.8M
-55.05%70.83M
-10.67%15.24M
-32.20%17.52M
-68.13%17.37M
Other operating expenses
----
-48.45%-1.72M
70.67%-44K
3.03%-64K
-661.43%-533K
-23.68%-1.08M
85.84%-1.16M
82.52%-150K
69.72%-66K
40.17%-70K
Operating profit
25.69%-14.12M
41.97%-66.82M
48.58%-14.46M
36.64%-16.97M
39.90%-16.39M
42.38%-19M
39.97%-115.14M
1.43%-28.11M
30.27%-26.79M
57.62%-27.27M
Net non-operating interest income expense
Other net income (expense)
-7.20%1.08M
126.05%4.81M
-15.88%996K
68.50%1.29M
417.94%1.36M
1,488.10%1.17M
1,066.82%2.13M
983.58%1.18M
25,600.00%765K
336.04%262K
Other non- operating income (expenses)
-7.20%1.08M
126.05%4.81M
-15.88%996K
68.50%1.29M
417.94%1.36M
1,488.10%1.17M
1,066.82%2.13M
983.58%1.18M
25,600.00%765K
336.04%262K
Income before tax
26.90%-13.04M
45.13%-62.01M
50.02%-13.46M
39.73%-15.68M
44.34%-15.03M
46.05%-17.83M
41.15%-113.01M
6.02%-26.93M
32.27%-26.02M
58.10%-27.01M
Income tax
Net income
26.90%-13.04M
45.13%-62.01M
50.02%-13.46M
39.73%-15.68M
44.34%-15.03M
46.05%-17.83M
41.15%-113.01M
6.02%-26.93M
32.27%-26.02M
58.10%-27.01M
Net income continuous Operations
26.90%-13.04M
45.13%-62.01M
50.02%-13.46M
39.73%-15.68M
44.34%-15.03M
46.05%-17.83M
41.15%-113.01M
6.02%-26.93M
32.27%-26.02M
58.10%-27.01M
Minority interest income
Net income attributable to the parent company
26.90%-13.04M
45.13%-62.01M
50.02%-13.46M
39.73%-15.68M
44.34%-15.03M
46.05%-17.83M
41.15%-113.01M
6.02%-26.93M
32.27%-26.02M
58.10%-27.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.90%-13.04M
45.13%-62.01M
50.02%-13.46M
39.73%-15.68M
44.34%-15.03M
46.05%-17.83M
41.15%-113.01M
6.02%-26.93M
32.27%-26.02M
58.10%-27.01M
Basic earnings per share
27.34%-7.15
45.64%-34.12
50.98%-7.39
40.30%-8.62
44.90%-8.27
47.52%-9.84
50.65%-62.77
7.38%-15.0746
35.39%-14.44
60.13%-15.01
Diluted earnings per share
27.34%-7.15
45.64%-34.12
50.98%-7.39
40.30%-8.62
44.90%-8.27
47.52%-9.84
50.65%-62.77
7.38%-15.0746
35.39%-14.44
60.13%-15.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -46.72%73K-88.72%412K41.12%151K-89.59%76K-90.44%48K-94.08%137K3.65M107K730K502K
Operating revenue -46.72%73K-88.72%412K41.12%151K-89.59%76K-90.44%48K-94.08%137K--3.65M--107K--730K--502K
Cost of revenue -70.00%6K-99.51%41K-99.66%8K-99.51%6K-99.46%7K-99.43%20K8.39M2.33M1.24M1.3M
Gross profit -42.74%67K107.83%371K106.43%143K113.83%70K105.13%41K109.69%117K-4.74M-2.23M-506K-800K
Operating expense -25.79%14.18M-39.14%67.19M-43.61%14.6M-35.16%17.04M-37.93%16.43M-39.82%19.11M-42.44%110.4M-9.23%25.89M-31.59%26.28M-58.87%26.47M
Selling and administrative expenses 82.08%11.65M-30.73%28.21M-38.85%6.6M-0.25%8.8M-30.16%6.41M-46.36%6.4M-3.98%40.73M-12.34%10.8M-31.01%8.83M-8.06%9.18M
Research and development costs -81.64%2.53M-42.55%40.69M-47.24%8.04M-52.62%8.3M-39.22%10.56M-33.36%13.8M-55.05%70.83M-10.67%15.24M-32.20%17.52M-68.13%17.37M
Other operating expenses -----48.45%-1.72M70.67%-44K3.03%-64K-661.43%-533K-23.68%-1.08M85.84%-1.16M82.52%-150K69.72%-66K40.17%-70K
Operating profit 25.69%-14.12M41.97%-66.82M48.58%-14.46M36.64%-16.97M39.90%-16.39M42.38%-19M39.97%-115.14M1.43%-28.11M30.27%-26.79M57.62%-27.27M
Net non-operating interest income expense
Other net income (expense) -7.20%1.08M126.05%4.81M-15.88%996K68.50%1.29M417.94%1.36M1,488.10%1.17M1,066.82%2.13M983.58%1.18M25,600.00%765K336.04%262K
Other non- operating income (expenses) -7.20%1.08M126.05%4.81M-15.88%996K68.50%1.29M417.94%1.36M1,488.10%1.17M1,066.82%2.13M983.58%1.18M25,600.00%765K336.04%262K
Income before tax 26.90%-13.04M45.13%-62.01M50.02%-13.46M39.73%-15.68M44.34%-15.03M46.05%-17.83M41.15%-113.01M6.02%-26.93M32.27%-26.02M58.10%-27.01M
Income tax
Net income 26.90%-13.04M45.13%-62.01M50.02%-13.46M39.73%-15.68M44.34%-15.03M46.05%-17.83M41.15%-113.01M6.02%-26.93M32.27%-26.02M58.10%-27.01M
Net income continuous Operations 26.90%-13.04M45.13%-62.01M50.02%-13.46M39.73%-15.68M44.34%-15.03M46.05%-17.83M41.15%-113.01M6.02%-26.93M32.27%-26.02M58.10%-27.01M
Minority interest income
Net income attributable to the parent company 26.90%-13.04M45.13%-62.01M50.02%-13.46M39.73%-15.68M44.34%-15.03M46.05%-17.83M41.15%-113.01M6.02%-26.93M32.27%-26.02M58.10%-27.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.90%-13.04M45.13%-62.01M50.02%-13.46M39.73%-15.68M44.34%-15.03M46.05%-17.83M41.15%-113.01M6.02%-26.93M32.27%-26.02M58.10%-27.01M
Basic earnings per share 27.34%-7.1545.64%-34.1250.98%-7.3940.30%-8.6244.90%-8.2747.52%-9.8450.65%-62.777.38%-15.074635.39%-14.4460.13%-15.01
Diluted earnings per share 27.34%-7.1545.64%-34.1250.98%-7.3940.30%-8.6244.90%-8.2747.52%-9.8450.65%-62.777.38%-15.074635.39%-14.4460.13%-15.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg